Liver Transplantation for Liver Rupture Due to Light Chain Deposition Disease: A Case Report

ABSTRACT

Light chain deposition disease (LCDD) is a rare pathologic condition distinct from amyloidosis. Amyloidosis is most often characterized by overproduction of lambda light chains, while kappa chains are overproduced in LCDD. In contrast to amyloid deposits, those of LCDD do not stain with Congo red and have a granular ultrastructure. LCDD primarily affects the kidney; clinically significant liver dysfunction is less common and less severe than renal disease. We describe a case of kappa chain deposition disease in a patient with plasma cell dyscrasia and platelet pool storage defect, which produced massive hepatomegaly and rupture of the liver leading to orthotopic liver transplantation. The liver weighed 6800 g and showed severe atrophy due to massive deposition of light chains. In this case, the deposits were composed of unbranched fibrils, which measured 12 to 20 nm in width, did not possess a hollow core, and were arranged randomly rather than in structured arrays.

KEYWORDS

Light chains - amyloid - transplantation - rupture - hepatomegaly

REFERENCES

• 1 Randall R E, Williamson Jr W C, Mullinax F et al.. Manifestations of systemic light chain deposition.  Am J Med. 1976;  60 293-299
• 2 Droz D, Noel L H, Carnot F et al.. Liver involvement in nonamyloid light chain deposits disease.  Lab Invest. 1984;  50 683-689
• 3 Ganeval D, Noel L H, Preud'homme J L et al.. Light-chain deposition disease: its relation with AL-type amyloidosis.  Kidney Int. 1984;  26 1-9
• 4 Bedossa P, Fabre M, Paraf F et al.. Light chain deposition disease with liver dysfunction.  Hum Pathol. 1988;  19 1008-1014
• 5 Faa G, Van Eyken P, De Vos R et al.. Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis.  J Hepatol. 1991;  12 75-82
• 6 Linder J, Croker B P, Vollmer R T, Shelburne J. Systemic kappa light-chain deposition: an ultrastructural and immunohistochemical study.  Am J Surg Pathol. 1983;  7 85-93
• 7 Pelletier G, Fabre M, Attali P et al.. Light chain deposition disease presenting with hepatomegaly: an association with amyloid-like fibrils.  Postgrad Med J. 1988;  64 804-808
• 8 Girelli C M, Lodi G, Rocca F. Kappa light chain deposition disease of the liver.  Eur J Gastroenterol Hepatol. 1998;  10 429-430
• 9 Gibson I W, More I AR. Glomerular pathology: recent advances.  J Pathol. 1998;  184 123-129
• 10 Bellotti V, Mangione P, Merlini G. Review: immunoglobulin light chain amyloidosis-the archetype of structural and pathogenic variability.  J Struct Biol. 2000;  130 280-289
• 11 Bellotti V, Stoppini M, Mangione P P et al.. Structural and functional characterization of three human immunoglobulin k light chains with different pathological implications.  Biochim Biophys Acta. 1996;  1317 161-167
• 12 Denoroy L, Deret S, Aucouturier P. Overrepresentation of the V kappa IV subgroup in light chain deposition disease.  Immunol Lett. 1994;  42 63-66
• 13 Hurle M R, Helms L R, Li L et al.. A role for destabilizing amino acid replacements in light-chain amyloidosis.  Proc Natl Acad Sci USA. 1994;  91 5446-5450
• 14 Rostagno A, Vidal R, Kaplan B et al.. pH-dependent fibrillogenesis of a VkappaIII Bence Jones protein.  Br J Haematol. 1999;  107 835-843
• 15 Helms L R, Wetzel R. Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis.  J Mol Biol. 1996;  257 77-86
• 16 Hofmann-Guilaine C, Nochy D, Jacquot C et al.. Association light chain deposition disease (LCDD) and amyloidosis: one case.  Pathol Res Pract. 1985;  180 214-219
• 17 Buxbaum J, Gallo G. Nonamyloidotic monoclonal immunoglobulin deposition disease: light-chain, heavy-chain and light- and heavy-chain deposition diseases.  Hematol Oncol Clin North Am. 1999;  13 1235-1248
• 18 Davis D P, Gallo G, Vogen S M et al.. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.  J Mol Biol. 2001;  313 1021-1034
• 19 Herrera G A, Shultz J J, Soong S J, Sanders P W. Growth factors in monoclonal light-chain-related renal diseases.  Hum Pathol. 1994;  25 883-892